Zephyrnet Logo

Tag: commercializing

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe...

ATLANTA, June 20, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide...

Top News

FDA Accepts Eisai’s Filing of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., June 10, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that that the U.S. Food...

Purdue Researchers Transform 2D Metal Halide Perovskites into 1D Nanowires

Purdue Researchers Transform 2D Metal Halide Perovskites into 1D Nanowires by Clarence Oxford Los Angeles CA (SPX) Jun 07, 2024 Purdue University engineers have developed a patent-pending...

IQT’s World Tour of Conferences Moves Next to Nordics Helsinki-Espoo 2024 – Inside Quantum Technology

IQT’s international event series moves next to Helsinki-Espoo, Finland June 24-26. IQT Nordics Helsinki-Espoo 2024 takes place in...

Lumenis introduces FoLix™, the first FDA-cleared proprietary fractional laser for hair loss treatment | BioSpace

YOKNE'AM ILLIT, Israel, June 5, 2024 /PRNewswire/ -- Lumenis Be. Ltd., a leading energy-based medical device company for aesthetic and eye care solutions, is proud...

Quantum: Photonic Demonstrates Distributed Entanglement between Modules – High-Performance Computing News Analysis | insideHPC

VANCOUVER, BC, May 30, 2024—Photonic Inc., a distributed quantum computing in silicon company, today announced what the company said is a milestone on the...

“LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea

TOKYO and CAMBRIDGE, Mass., May 28, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Food...

LQUOM CFO Yuya Mochizuki is an IQT Vancouver/Pacific Rim 2024 Conference Speaker – Inside Quantum Technology

By Kenna Hughes-Castleberry posted 18 May 2024 Yuya Mochizuki, the Chief Financial Officer of LQUOM, is slated to...

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under...

TOKYO and CAMBRIDGE, Mass., May 15, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has...

RAG architecture with Voyage AI embedding models on Amazon SageMaker JumpStart and Anthropic Claude 3 models | Amazon Web Services

This post is a guest post co-written with Tengyu Ma and Wen Phan from Voyage AI. Organizations...

CV SCIENCES INC. ACQUIRES ELEVATED SOFTGELS

SAN DIEGO — CV Sciences, Inc., a consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, consummated its purchase...

Boston Dynamics Says Farewell to Its Humanoid Atlas Robot—Then Brings It Back Fully Electric

Yesterday, Boston Dynamics announced it was retiring its hydraulic Atlas robot. Atlas has long been the standard bearer of advanced humanoid robots. Over the...

Atlas shrugged: Boston Dynamics retires its hydraulic humanoid robot – Autoblog

Robert Playter, CEO of Boston Dynamics, with Atlas. (Boston Globe via Getty Images) Now that humanoids are all the rage in the robotics...

Latest Intelligence

spot_img
spot_img